Suggestions

Du même auteur

First-line pembrolizumab with or without platinum doublet chemotherapy in non-small-cell lung cancer patients with PD-L1 expression ≥50%

Archive ouverte | Descourt, Renaud | CCSD

International audience. Pembrolizumab plus chemotherapy is currently used in the first-line treatment of advanced non-small-cell lung cancer without EGFR mutations or ALK rearrangements, regardless of PD-L1 expressi...

Efficacy and safety of programmed cell-death-protein-1 and its ligand inhibitors in pretreated patients with epidermal growth-factor receptor-mutated or anaplastic lymphoma kinase-translocated lung adenocarcinoma

Archive ouverte | Bylicki, Olivier | CCSD

International audience. Immune-checkpoint inhibitor (ICI) efficacy in patients with non-small cell lung cancer (NSCLC) harboring molecular alterations remains poorly elucidated. This study was undertaken to determin...

Assessment of preoperative noninvasive ventilation before lung cancer surgery: The preOVNI randomized controlled study

Archive ouverte | Tromeur, Cécile | CCSD

International audience

Chargement des enrichissements...